ArticleCancer immunology, immunotherapy : CII2024

TLR5 agonist in combination with anti-PD-1 treatment enhances anti-tumor effect through M1/M2 macrophage polarization shift and CD8

Junseok Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.